Osteogenesis Imperfecta Treatment Market - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Osteogenesis Imperfecta Treatment Market

Description:

Read here the market research report . – PowerPoint PPT presentation

Number of Views:0
Date added: 10 November 2020
Slides: 15
Provided by: PRIYACMI
Category:
Tags:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Osteogenesis Imperfecta Treatment Market


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
OSTEOGENESIS IMPERFECTA TREATMENT MARKET
ANALYSIS
  • Osteogenesis Imperfecta Treatment Market, by
    Drugs (Teriparatide, Denosumab, and Others) By
    Route of Administration (Subcutaneous,
    Intravenous, Oral, and Others), and by Region
    (North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa) - Size, Share,
    Outlook, and Opportunity Analysis, 2020 - 2027

3
  • Osteogenesis imperfecta (OI) is a type of orphan
    disease group, characterized by varying degrees
    of skeletal fragility such as low bone mass and a
    propensity to fracture. This condition is caused
    due to the mutations in the COL1A1 or COL1A2 gene
    that encodes the alpha chains of collagen
    produced by osteoblasts. These genes are
    susceptible to different mutations for the
    production of fibrils.
  • Osteogenesis Imperfecta Treatment Market - Impact
    of Coronavirus (Covid-19) Pandemic
  • Osteogenesis imperfecta (OI) treatment market is
    adversely affected due to the outbreak of
    COVID-19, as it is becoming difficult for
    researchers to conduct researches during this
    pandemic. Though OI does not affect the immune
    system, lung connective tissue is distorted in
    all types of OI. The risk of pulmonary problems
    and severity of symptoms is high in people with
    abnormal chest shape, short stature, rib or
    vertebral fractures, and kyphoscoliosis

4
Impact of Coronavirus (Covid-19) Pandemic
  • The osteogenesis imperfecta treatment market is
    estimated to be valued at US 684.2 million in
    2020 and is expected to rise at a CAGR of
    1.90 during the forecast period (2020-2027).

5
Figure 1. Osteogenesis Imperfecta Treatment
Market Share () Analysis, By Route of
Administration, 2020
6
Osteogenesis Imperfecta Treatment Market
  • The non-availability of effective treatment for
    osteogenesis imperfecta is expected to hinder the
    market growth during the forecast period.
    Moreover, the shortage of trained professionals
    in some low- and middle-income countries is
    likely to hamper the market growth.

7
(No Transcript)
8
  • Osteogenesis Imperfecta Treatment Market
    Regional Analysis
  • Europe region accounted for the largest share in
    the osteogenesis imperfecta treatment market in
    2019, owing to increasing focus of key players on
    research development and rise in the number of
    clinical trials for the treatment of osteogenesis
    imperfecta. For instance, Bone Therapeutics SA
    received an Orphan Drug designation from the
    Europe Medicines Agency (EMA) as well as the FDA
    for ALLOB, which is an allogeneic bone cell
    therapy product for osteogenesis imperfect
    treatment. A product with Orphan Drug designation
    recevies certain incentives and benefits along
    with a period of 10 years market exclusivity,
    protocol assistance, and reduced regulatory fees
    upon approval.

9
Figure 2. Osteogenesis Imperfecta Treatment
Market Value (US Mn) Y-o-Y Growth (),
2017-2027
10
  • Osteogenesis Imperfecta Treatment Market -
    Competitive Landscape
  • Key players operating in the osteogenesis
    imperfecta treatment market include Bone
    Therapeutics SA, Mereo BioPharma Group plc,
    Celgene Corporation, Eli Lilly and Company, Cipla
    Inc., Amgen Inc, Sun Pharmaceutical Industries
    Limited, Mylan N.V., Teva Pharmaceutical
    Industries Ltd, Merck Co., Inc., Jubilant Life
    Sciences Ltd., Aurobindo Pharma, and Genzyme
    Corp.

11
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//www.coherentmarketinsights.com/m
    arket-insight/osteogenesis-imperfecta-treatment-ma
    rket-4064

12
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

13
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

14
  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com